NCT04307654

Completed

Lactate and Complications in Cytoreduction Surgery for Perit...

Hospital General Universitario de Castellón Source

Compare

Other study identifiers

Sponsor study identifier

HGCLAC01

Study Type

observational

Actual enrollment (reported)

57

Locations

0 countries

Sites

N/A

Timeline

Study Start

January 2014

Actual (reported)

Primary Completion

June 2014

Actual (reported)

Study Completion

January 2016

Actual (reported)

Brief Summary

Serum lactate is a risk factor for postoperative complications in patients undergoing cytoreduction surgery in peritoneal carcinomatosis

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 57 participants
Study completion date: January 2016
Actual (reported)
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
January 2014
Actual (reported)
Primary Completion
June 2014
Actual (reported)
Study Completion
January 2016
Actual (reported)
First Submitted
March 9, 2020
Actual (reported)
First Posted
March 13, 2020
Actual (reported)

Last Updated: March 13, 2020
Status Verified: March 2020
Last Update Submitted: March 12, 2020

Conditions

Lactacidemia and Complications

Keywords

lactic acidCytoreductive surgerypostoperative complications

Outcome Measures

Primary Outcomes (1)

Postoperative complications
complications in patients undergoing cytoreduction surgery during the immediate postoperative period in the Intensive Care Unit (ICU) at the General Hospital of Castellón (HGCS) between 2014 and 2016.
2014-2016

Eligibility Criteria

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

patients diagnosed with peritoneal carcinomatosis who underwent cytoreduction surgery in the Multidisciplinary Unit of Abdomino-Pelvic Oncology Surgery (MUAPOS) of the University General Hospital of Castellón

You may qualify if:

patients diagnosed with peritoneal carcinomatosis who underwent cytoreduction surgery in the Multidisciplinary Unit of Abdomino-Pelvic Oncology Surgery (MUAPOS) of the University General Hospital of Castellón.

Sponsors & Collaborators

Hospital General Universitario de Castellón
Otherlead

MeSH Terms

Conditions

Postoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Enrollment

57 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Principal investigator

Study Record Dates

First Submitted

March 9, 2020

First Posted

March 13, 2020

Study Start

January 2014

Actual (reported)

You may not qualify if:

patients without lactic acid levels in the register.

Contact the study team to confirm eligibility.

Primary Completion

June 2014

Actual (reported)

Study Completion

January 2016

Actual (reported)

Last Updated

March 13, 2020

Record last verified: 2020-03

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT04307654
Data provider: ClinicalTrials.gov
Source updated: 2020-03-13
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:33:10 UTC

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record